Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention

Internal and Emergency Medicine

Volumn 4, Issue 5, 2009, Pages 403-408

  Picariello, Claudio ^a   Lazzeri, Chiara ^a   Chiostri, Marco ^a   Gensini, Gianfranco ^a   Valente, Serafina ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Cardiogenic shock; Procalcitonin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BLOOD; CARDIOGENIC SHOCK; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; ITALY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INFLAMMATION; INTENSIVE CARE UNITS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROTEIN PRECURSORS; SHOCK, CARDIOGENIC;

EID: 71449092773     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-009-0277-9     Document Type: Article

References (21)

1. Conlon JM, Grimelius L, Thim L (1988) Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma. Biochem J. 256: 245-250.
2. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34: 1996-2003.
3. Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K (2003) Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 29: 1384-1389.
4. Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, Baltopoulos G, Maniatis P, Cokkinos DV (2008) Procalcitonin in acute myocardial infarction. Acute Card Care 10: 30-36.
5. Remskar M, Horvat M, Hojker S, Noc M (2002) Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 114: 205-210.
6. Buratti T, Ricevuti G, Pechlaner C, Joannidis M, Wiedermann FJ, Gritti D, Herold M, Wiedermann CJ (2001) Plasma levels of procalcitonin and interleukin-6 in IMA. Inflammation 25: 97-100.
7. Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330: 1724-1730.
8. Holmes DR Jr (2003) Cardiogenic shock: a lethal complication of acute myocardial infarction. Rev Cardiovasc Med 4: 131-135 Review.
9. Hochman JS (2003) Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107: 2998-3002.
10. Webb JG, Lowe AM, Sanborn TA et al (2003) Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial: SHOCK Investigators. J Am Coll Cardiol 42: 1380-1386.
11. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, Comeglio M, Chiocchini S, Gensini GF (2007) Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol 114: 176-182.
12. Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Salvadori C, Gensini GF (2008) Time of onset and outcome of cardiogenic shock in acute coronary syndromes. J Cardiovasc Med (Hagerstown) 9: 1235-1240.
13. Thygesen K, Alpert JS, White HD (2007) Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Universal Definition of Myocardial Infarction. J Am Coll Cardiol 50: 2173-2195.
14. ACC/AHA (2007) Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol 50: e1-e157.
15. Whicher J, Bienvenu J, Monneret G (2001) Procalcitonin as an acute phase marker. Ann Clin Biochem 38: 483-493.
16. Nijsten MW, Olinga P, The TH et al (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28: 458-461.
17. Oberhoffer M, Stonans I, Russwurm S et al (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134: 49-55.
18. Sentürk T, Cordan J, Baran I, Ozdemir B, Güllülü S, Aydinlar A, Göral G (2007) Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 62: 135-141.
19. Brunkhorst FM, Clark AL, Forycki ZF, Anker SD (1999) Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol 72: 3-10.
20. Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, Célard M, Vandenesch F, Rousson R, Lehot JJ (2000) Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 28: 3171-3176.
21. de Werra I, Jaccard C, Corradin SB, Chioléro R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, Heumann D (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25: 607-613.